Johnson & Johnson's top three insider shareholders as of September 29, 2026 are Alex Gorsky (Chairman, Ceo, 766.58K shares), Joaquin Duato (Ceo And Chairman Of The Board, 275.97K shares), Jennifer L Taubert (Evp, Wwc. Innovative Medicine, 194.45K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Alex Gorsky | Chairman, Ceo | 766,584 | 0 | 766,584 | 38.4% | 18 Jan, 2023 |
| 2 | Joaquin Duato | Ceo And Chairman Of The Board | 275,967 | 0 | 275,967 | 13.8% | 14 Aug, 2026 |
| 3 | Jennifer L Taubert | Evp, Wwc. Innovative Medicine | 194,451 | 0 | 194,451 | 9.7% | 18 Aug, 2026 |
| 4 | Michael H Ullmann | Exec Vp, General Counsel | 158,835 | 0 | 158,835 | 8.0% | 16 Feb, 2022 |
| 5 | Kathryn E Wengel | Evp, Chief To And Risk Officer | 114,288 | 0 | 114,288 | 5.7% | 12 Jun, 2026 |
| 6 | Peter Fasolo | Exec Vp, Chief Hr Officer | 112,076 | 0 | 112,076 | 5.6% | 15 Feb, 2024 |
| 7 | Thibaut Mongon | Exec Vp, Ww Chair, Cons Health | 65,915 | 0 | 65,915 | 3.3% | 15 Feb, 2023 |
| 8 | Ashley Mcevoy | Evp, Ww Chair, Medtech | 52,038 | 0 | 52,038 | 2.6% | 25 Aug, 2023 |
| 9 | Mathai Mammen | Evp, Pharm, Rd | 41,934 | 0 | 41,934 | 2.1% | 16 Feb, 2022 |
| 10 | William Hait | Officer | 38,647 | 0 | 38,647 | 1.9% | 15 Feb, 2024 |
| 11 | James D. Swanson | Evp, Cio | 25,698 | 0 | 25,698 | 1.3% | 18 Feb, 2026 |
| 12 | Timothy Schmid | Evp, Ww Chair, Medtech | 25,447 | 0 | 25,447 | 1.3% | 04 Sep, 2026 |
| 13 | John C Reed | Evp, Innovative Medicine, Rd | 24,911 | 0 | 24,911 | 1.2% | 04 May, 2026 |
| 14 | Robert J Decker | Vp Corporate Controller | 23,682 | 0 | 23,682 | 1.2% | 03 Mar, 2026 |
| 15 | Vanessa Broadhurst | Evp, Global Corp Affairs | 23,003 | 0 | 23,003 | 1.2% | 21 Jul, 2026 |
| 16 | Kristen Mulholland | Evp, Chief Hr Officer | 19,830 | 0 | 19,830 | 1.0% | 18 Feb, 2026 |
| 17 | Elizabeth Forminard | Evp, Chief Legal Officer | 16,994 | 0 | 16,994 | 0.9% | 07 Aug, 2026 |
| 18 | Joseph J Wolk | Exec Vp, Cfo | 14,000 | 0 | 14,000 | 0.7% | 18 Feb, 2026 |
| 19 | John G Morikis | Director | 1,849 | 0 | 1,849 | 0.1% | 01 Dec, 2025 |
| 20 | Mark A Weinberger | Director | 1,000 | 0 | 1,000 | 0.1% | 12 Dec, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 08 Sep, 2026 | Daniel E Pinto | Director | Acquired A | 113 | $276.31 | $31.25K | 2,445 | Direct |
| 08 Sep, 2026 | Marillyn A Hewson | Director | Acquired A | 181 | $276.31 | $50.00K | 16,049 | Direct |
| 08 Sep, 2026 | Eugene A. Woods | Director | Acquired A | 136 | $276.31 | $37.50K | 6,579 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Acquired M | 11,070 | $131.94 | $1.46Mn | 36,517 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Disposed S | 11,070 | $274.74 | $3.04Mn | 25,447 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Acquired M | 22,527 | $151.41 | $3.41Mn | 47,974 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Disposed S | 22,527 | $274.74 | $6.19Mn | 25,447 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Disposed M | 11,070 | $0.00 | $0 | 0 | Direct |
| 02 Sep, 2026 | Timothy Schmid | Evp, Ww Chair, Medtech | Disposed M | 22,527 | $0.00 | $0 | 0 | Direct |
| 17 Aug, 2026 | Jennifer L Taubert | Evp, Wwc. Innovative Medicine | Acquired M | 15,000 | $115.67 | $1.74Mn | 209,451 | Direct |
| 17 Aug, 2026 | Jennifer L Taubert | Evp, Wwc. Innovative Medicine | Disposed S | 15,000 | $263.36 | $3.95Mn | 194,451 | Direct |
| 17 Aug, 2026 | Jennifer L Taubert | Evp, Wwc. Innovative Medicine | Disposed M | 15,000 | $0.00 | $0 | 28,712 | Direct |
| 13 Aug, 2026 | Joaquin Duato | Ceo And Chairman Of The Board | Acquired M | 123,291 | $115.67 | $14.26Mn | 399,258 | Direct |
| 13 Aug, 2026 | Joaquin Duato | Ceo And Chairman Of The Board | Disposed S | 20,976 | $262.00 | $5.50Mn | 378,282 | Direct |
| 13 Aug, 2026 | Joaquin Duato | Ceo And Chairman Of The Board | Disposed S | 102,315 | $261.00 | $26.70Mn | 275,967 | Direct |
| 13 Aug, 2026 | Joaquin Duato | Ceo And Chairman Of The Board | Disposed M | 123,291 | $0.00 | $0 | 0 | Direct |
| 05 Aug, 2026 | Joaquin Duato | Ceo And Chairman Of The Board | Disposed S | 41,957 | $258.06 | $10.83Mn | 282,490 | Direct |
| 06 Aug, 2026 | Elizabeth Forminard | Evp, Chief Legal Officer | Acquired M | 9,344 | $131.94 | $1.23Mn | 32,912 | Direct |
| 05 Aug, 2026 | Joaquin Duato | Ceo And Chairman Of The Board | Disposed S | 6,523 | $258.74 | $1.69Mn | 275,967 | Direct |
| 06 Aug, 2026 | Elizabeth Forminard | Evp, Chief Legal Officer | Disposed S | 9,344 | $257.76 | $2.41Mn | 23,568 | Direct |